tm logo

Monitor this mark

View On USPTO

CELLBIXAN
Live/Registered
REGISTERED

on 01 Oct 2024

Last Applicant/ Owned by

Serial Number

79379913 filed on 19th Jul 2023

Registration Number

7518485 registered on 01st Oct 2024

in the Principal Register

Correspondent Address

James R. Davis, II

James R. Davis, II Perkins Coie LLP

Seattle, WA 98111

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

CELLBIXAN

Anti-CD20 recombinant monoclonal antibody for medical use

Classification Information

Class [005]
Pharmaceutical Products

Anti-CD20 recombinant monoclonal antibody for medical use

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79379913

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 142627-4037

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
01st Oct 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
01st Oct 2024REGISTERED-PRINCIPAL REGISTER
16th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Jul 2024PUBLISHED FOR OPPOSITION
26th Jun 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13th Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
14th May 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
14th May 2024TEAS/EMAIL CORRESPONDENCE ENTERED
14th May 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
08th May 2024REFUSAL PROCESSED BY IB